• WCG’s eCOA portfolio and imaging analysis technology from NeuroRx are now part of Clario!

menu-close-icon
Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • Study Endpoints
        • Cardiac safety and efficacy endpoint solutions for all phases, anywhere in the world.

        • Collect continuous ECG data in site-based or hybrid trials with our flexible solutions and patient-friendly devices.

        • Collect and centrally analyze accurate, consistent, quality blood pressure data from site-based to hybrid trials.

        • Monitor every heartbeat with precision to assess safety and efficacy throughout your site-based or hybrid clinical trial.

        • Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial.

        • Leverage our key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.

        • Make your clinical trials easier, faster, more engaging and accessible to all.

        • Enjoy flexible, fast and confidential site assessments at home.

        • Enhance your ePRO data with photo and audio capture.

        • Accelerate your clinical trial setup with Clario’s pre-validated and configured eCOA assessments.

        • Improve data accuracy and reduce variability in scoring with Clario’s training solutions.

        • Your trusted partner for the richest eCOA endpoint data in your clinical trial.

        • Monitor Suicide Ideation and Behavior (SIB) in clinical trials effectively with Clario’s suicide assessment tool, eC-SSRS.

        • Accelerate drug development and reduce risk with Clario’s comprehensive medical imaging core lab services.

        • The Clario team includes medical imaging experts and globally recognized key opinion leaders (KOLs) representing multiple disciplines.

        • Clario’s Image Redact AI automatically redacts sensitive patient identifiers from videos, photos and PDFs.

        • Secure accurate results, streamline your processes, and meet your unique needs with our imaging platform.

        • Leverage our full range of medical imaging and diagnostic imaging modalities, including CT Scans, Endoscopy, MRIs, and more.

        • Securely collect, store, and share de-identified images for compliance with 21 CFR Part 11 and EU GDPR standards.

        • Clario's complete solution for measuring objective digital endpoints of mobility with wearable sensor technology.

        • The Opal V2R® is a research grade wearable sensor that delivers meaningful outcomes and richer insights.

        • Explore more than 750 scientific publications that reflect the technical and clinical applications of Clario’s Opal® System.

        • Everything you need for high quality, low variability pulmonary function data and high patient compliance for clinical trials.

        • Centralized, on-site pulmonary function testing for clinical trials.

        • Remote spirometry testing for respiratory clinical trials.

        • Assess cough frequency, cough severity and other lung sounds such as crackles or rhonchi for clinical trials.

        • Assess the capacity of the lungs for effective gas transfer.

        • Advanced, cloud-native technologies and clinical trial software to screen, clean, QC and assess complicated data.

        • Collect, centralize and manage participant screening and eligibility data with customized workflows.

        • Boost stakeholder insights with business intelligence (BI) tools, analytics for endpoint and safety risks, and data exchange solutions.

        • Securely collect, store and share compliant images in the cloud to keep clinical trial sponsors and labs informed.

    • Segments
    • Study Phases
    • Technology
  • Therapeutic Areas
    • Cardiovascular & Metabolic Icon RGBCardiovascular & Metabolic
    • Dermatology Icon RGBDermatology
    • Type 2 Diabetes and Obesity iconDiabetes and Obesity
    • Gastroenterology Icon RGBGastroenterology
    • Hepatology Icon RGBHepatology
    • Infectious Disease Icon RGBInfectious Diseases
    • Muskoskeletal Icon RGBMusculoskeletal
    • Neuroscience Icon RGBNeuroscience
      • Neuroscience Indications
    • Oncology Icon RGBOncology
    • Ophthalmology Icon RGBOphthalmology
    • Respiratory Solutions IconRespiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Solutions
    • eCOA Clinical Trials
      • eCOA Clinical Trials
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rapid Start
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Artificial Intelligence (AI)
    • Cardiac Solutions
      • Cardiac Solutions
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • Image Redact AI
      • Imaging Platform
      • Modalities
      • SMART Submit
    • Precision Motion
      • Precision Motion for Clinical Trials
      • Precision Motion for Research
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Site-Based Spirometry (FEV1, FVC, PEF, and more.)
      • Virtual Home Spirometry
      • Cough and Lung Sounds
      • Diffusing Capacity (DLCO)
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Eligibility Solution
      • Reporting & Analytics
      • Source Document Manager
    • Hybrid Trials
    • Biotechs
    • CROs
    • Pharma
    • Phase I
    • Phase II/III
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
    • Oncology
    • Ophthalmology
    • Type 2 Diabetes and Obesity
    • Respiratory Solutions
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Contact sales
  1. Home Resources Blog Articles Three ways to increase patient diversity in clinical trials

Three ways to increase patient diversity in clinical trials

Safe and effective treatments for all are only possible if there is patient diversity in the clinical trials of those treatments

Otis Johnson, Ph.D., M.P.A. – Chief Diversity, Inclusion, and Sustainability Officer at Clario

Each year, clinical trials deliver dozens of life-saving solutions to the market. However, a startling lack of diversity in the people on these trials potentially puts lives at risk and can lead to poorer outcomes for diverse patients.

According to Tufts Center for the Study of Drug Development (CSDD), the representation of Black people in trials for FDA-approved drugs during the period 2007–2017 was 65 percent below census levels and disease population. This powerful statistic demonstrates the dangerous underrepresentation of minorities in clinical trials.

Safe and effective treatments for all are only possible if there is patient diversity in the clinical trials of those treatments. As a leading provider of rich clinical evidence for our customers, we believe it is our responsibility to drive forward diversity in clinical trials. In a recent MedCity News article, I outlined three key actions I believe will achieve more diverse patient populations in clinical trials: increase education and restore patient trust, improve access to trials, and drive diversity in the clinical trial workforce. Here, I dive deeper into each of these areas.

Increasing Education and Restoring Patient Trust

The lack of patient diversity in clinical trials is a dangerous problem, but we rarely use this type of language to communicate the extent of the problem. Given the current lack of diversity in trials, a loved one could begin taking medication for a life-threatening condition without knowing whether it will truly be effective, because it was not tested on enough people like them. This is a dangerous proposition, yet it is the reality for many, and we need to discuss these potential consequences. We must change the way we talk about participating in clinical trials and talk about the importance of diversity and inclusion in trials and studies through impactful messaging that invokes emotion, empathy and action.

The lack of education about the value of clinical trials is also a significant contributor to the lack of trial participation within the Black community. As I shared in the recent MedCity News article, to reach a more diverse patient population, we must restore trust, broken by historical events like the Tuskegee Syphilis study and wrestling with cancer treatment advancements due to the cells of Henrietta Lacks being collected and used without her consent, to strengthen familiarity among diverse patient communities and the general public. This is an area Clario employees are working on already. Our employee resource groups (ERGs) are developing an inclusive toolkit for clinical sites to help them when speaking with minority patients about clinical trials. We are also working with CISCRP, an organization that advertises in print and digital publications that target geographies with high minority populations, to promote participation and raise public awareness about the importance of patient diversity in clinical trials.

Improving Access to Clinical Trials

We can work to improve health equity by increasing access to trials through remote, hybrid and decentralized clinical trial (DCT) models that bring trials to areas with diverse populations, rather than asking them to come to trial sites (an option often unavailable or that creates a major inconvenience to many in diverse communities). According to another Tufts CSDD study, access to studies (e.g., transportation issues and lack of minority clinical investigators) contributed to a lack of participation in non-white communities.2 Similarly, the remote model offers participants the opportunity to take part in trials from the comfort of their own home while mitigating bias experienced at on-site trials.

Given the various benefits of DCTs, we must encourage and enable clinical trial sponsors and contract research organizations (CROs) to take their trials into diverse communities. This is why Clario is focusing on our decentralized trials technology portfolio and scientific expertise, to enable sponsors to collect high-quality endpoint data from any modality or location while improving the patient experience.

Driving Clinical Trial Workforce Diversity

It is well-known that a person is more willing to participate in a clinical trial if someone who looks like them informs them of the opportunity.

Clario is working with industry organizations that play a vital role in solving the lack of patient diversity in clinical trials. For example, the Association of Clinical Research Organizations (ACRO) is committed to building a clinical research ecosystem that represents the world we live in, and the Association of Clinical Research Professionals (ACRP) focuses on growing the diversity of the clinical trial workforce and developing the existing workforce. We have a seat on the diversity advisory committee of both industry organizations and are working hard with them to identify the steps needed to solve these problems.

We are also working to do our part to improve the diversity of the clinical trial workforce. We are launching an internship program in partnership with Wake Forest University to bring more women and minorities into the clinical trial workforce. This internship program is only one example of an ongoing solution to a dangerous problem. We need more organizations and universities to join together and foster relationships to bring new generations into clinical research, supporting diversity and inclusion in the industry workforce to bolster trust and participation.

In closing, we need to ensure clinical trials are accessible to all. The whole industry must intensify its efforts by offering more inclusive educational materials, bringing trials into Black and other minority communities, increasing representation in the workforce, restoring trust and saving lives. These actions will ultimately improve the quality of life for all, and not just those who have traditionally been able to access or trust clinical trials.

Pioneering the path of drug development

Interested in how Clario is collaborating with industry leaders to shape the future of drug research? Delve into our joint efforts with the Tufts Center for the Study of Drug Development (CSDD) in our latest research report.

Learn more
Back to articles
Share
Twitter Facebook LinkedIn

Latest articles

See all articles
Article

Researcher spotlight: Dr. Lauren Tueth

Precision Motion

Read
Article

Researcher spotlight: Brice Cleland

Precision Motion

Read
Article

Researcher spotlight: Josefa Domingos

Precision Motion

Read
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Contact sales

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.


Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

  • © 2025 Clario

    • Legal and Privacy Terms
    • Information Security
    • Cookie Policy
    • Impressum